APNA 29th Annual Conference Session 2022: October 29, 2015 - - PDF document

apna 29th annual conference session 2022 october 29 2015
SMART_READER_LITE
LIVE PREVIEW

APNA 29th Annual Conference Session 2022: October 29, 2015 - - PDF document

APNA 29th Annual Conference Session 2022: October 29, 2015 Differential Diagnosis in the Integrated Care Setting for Anxious Woman with Visual/Tactile Hallucinations: A Case Review Pamela Stover DNP, ARNP, PMHNP-BC, PMHCNS-BC No conflict


slide-1
SLIDE 1

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 1

Differential Diagnosis in the Integrated Care Setting for Anxious Woman with Visual/Tactile Hallucinations: A Case Review

Pamela Stover DNP, ARNP, PMHNP-BC, PMHCNS-BC No conflict of interest to disclose

Objectives

Describe the important aspects of the case patient, in terms of history, presentation, diagnosis, and treatment plan Analyze and appraise the differential diagnoses for case patient with visual/tactile hallucinations and describe the important elements of and the implications of the proposed diagnosis Discuss the contribution of integrated care values and competencies to the diagnosis and care of the identified patient and the role of the PMHNP

The Patient

59 yo female

Marital Status: hx of divorce; fiancé died of cancer Offspring: 3 children, 2 grandchildren Living situation: rents a home, alone Family psych hx: depression > mother and brother Trauma hx: physical/mental abuse as child & adult Employment hx: medical office

slide-2
SLIDE 2

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 2

The Patient (cont’d)

Medical problems: obesity, GERD, osteopenia, DJD Medication allergies: NKDA Socialization: isolates, online virtual gaming & relationships Sleep: deprivation Support system: neighbor/friend helps, uses meth; local family Disability: due to agoraphobia

The Patient (cont’d)

Psych Hx

  • 1 suicide attempt
  • 1 psych

hospitalization

  • Hx dysthymia
  • Hx cyclothymia
  • R/O bipolar disorder
  • Outpt tx for ADD,

OCD, anxiety, agoraphobia

Substance Use Hx

  • Forced cocaine and

THC use by ex- husband

  • Hx valium for coping
  • Occasional meth use

if offered

  • Marijuana for sleep,

anxiety, appetite

Referral to Behavioral Health

Sports medicine physician evaluated wrist pain Referred for agoraphobia Initiated November 2014

slide-3
SLIDE 3

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 3

The Initial Encounter– 1/21/2015

  • agoraphobia

Referral reason:

  • “worms” on/in body, causing major

distress

Identified problem:

  • anxiety, agoraphobia, panic

attacks, PTSD, sleep deprivation

Additional problems:

  • sertraline 100 mg QD,
  • bupropion XL 300 mg po QD
  • clonazepam 1 mg QD prn anxiety

Starting meds:

Initial Diagnosis and Plan

Initial visit

  • 1/21/2015 for assessment (referred 11/17/14).

Dx

  • PTSD, agoraphobia, psychosis NOS
  • rule outs--medical cause of hallucinations,

delusional disorder/somatic type, psychotic disorder due to medical condition, others Plan

  • Meds: continue bupropion XL, clonazepam prn

anxiety; increase Sertraline

  • Consultation with MD: labs & CT head ordered
  • Return visit: in 1 week, for follow-up, lab work and

CT of head, and x-rays delayed from fall

Progression of Care

Next visit: 1/29/2015 for f/u; c/o panic, depression, nightmares, hallucinations/worms, dizziness

  • Plan: continue bupropion,

sertraline, clonazepam, add prazosin, risperidone; return in 1 week.

  • Dx: PTSD, agoraphobia,

psychosis unspecified, add depressive disorder unspecified. Next visit: 2/11/2015 for f/u; labs WNL, but + for meth; calmer; no visual hallucinations x 2 days; quit meth; sleeping more; happy tears

  • Plan: continue meds
  • Diagnosis: no change
slide-4
SLIDE 4

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 4

Progression of Care (cont’d)

Next visits:

  • 2/18/2015, then none for 6 months
  • Concerns about panic attack, visual

hallucinations (worms and other)

  • More optimistic
  • Episodic relapse on meth with friend,

subsequent remorse, and abstinence; later shame disrupted treatment

  • Ambivalence about relationship with friend
  • Self-discontinued risperidone in May

Differential Diagnoses

Non-psychiatric rule-outs for visual/tactile hallucinations

  • Retinal pathology
  • Migraine headaches
  • Charles Bonnet syndrome
  • Occipital seizures
  • Dementia due to Lewy bodies or Creutzfeldt-Jakob disease
  • Delirium
  • Parkinson’s disease
  • Substance intoxication or withdrawal
  • Metabolic disorders
  • Neurologic disease or tumor
  • Diminished visual acuity
  • Sleep, food, or sensory deprivation
  • Fatigue
  • Prolonged isolation (Prerost, Sefcik, & Smith, 2014)

Psychiatric Differential Diagnoses

  • Schizophrenia
  • Schizoaffective disorder
  • Schizophreniform disorder
  • Brief psychotic disorder
  • Delusional disorder
  • Bipolar disorder type I
  • Major depressive disorder
  • Postpartum depression
  • Conversion disorder
  • PTSD
  • Schizotypal personality

disorder

  • BPD
  • Substance intoxication/

withdrawal/induced psychotic disorder

  • Dementia
  • Delirium (Prerost et al.,2014)
slide-5
SLIDE 5

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 5

What do you think?

  • Based on the information provided —
  • Would you select a medical or psychiatric

diagnosis to account for the patient’s hallucinations and distress about worms living in her body?

  • Which diagnosis would you choose?

Delusions of parasitosis

“A psychiatric condition … a fixed, false belief … infested with parasites … hallucinatory experiences compatible with this delusion.” (Levin & Gieler, 2013)

  • Historically called parasitophobia
  • A monosymptomatic hypochondriacal psychosis–

delusional idea with a single concern seen as cause

  • Primary or secondary condition
  • Primary-persistent delusional disorder per ICD-10;

delusional disorder, somatic type, per DSM IV

  • Secondary-arises from medical conditions, i.e.

CVA, CVD, B12 deficiency, diabetes, schizophrenia, depression, cocaine or amphetamine toxicity (Levin & Gieler, 2013)

Parasitosis

  • Onset in 50s or 60s, more common in females

Epidemiology

  • Hallucinatory experience of biting/stinging, leads to

delusion OR

  • Primary delusion leads to perception of associated

feelings Pathogenesis

  • Multiple attempts to rid self of parasites
  • Presentation of evidence of perceived infestation
  • Skin – normal appearance; or excoriation,

lichenification, prurigo nodularis, erosions, ulceration related to digging out parasites (Levin & Gieler, 2013) Clinical presentation

slide-6
SLIDE 6

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 6

Parasitosis (cont’d)

  • Rule out true primary skin disorder
  • Formication: primary idiopathic vs, secondary

neurological disorder or substance abuse (relief occurs with cessation of substance use) Further differential diagnosis

  • Establish therapeutic alliance & determine if patient

goal is symptom relief or convincing others about delusion

  • Perform a thorough history & exam, possibly

including lab tests

  • Initiate & maintain pharmacologic therapy —

pimozide, risperidone, olanzapine

(Levin & Gieler, 2013)

Management

The Clinical Setting

Medical Group—

  • utpatient

clinical services Family Medicine Clinic/primary care setting Behavioral health integration

  • Part of larger system in

Alaska, Washington, Oregon

  • Hospitals, outpatient

clinics, laboratories

  • Hired PMHNP July 2014
  • Community mental health

affiliation-February 2015

  • Future of behavioral

health?

Integrated Care Competencies

INTERPERSONAL COMMUNICATION COLLABORATION & TEAMWORK SCREENING & ASSESSMENT CARE PLANNING & CARE COORDINATION INTERVENTION (Hoge et al., 2014)

slide-7
SLIDE 7

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 7

Integrated Care Competencies (cont’d)

CULTURAL COMPETENCE & ADAPTATION SYSTEMS ORIENTED PRACTICE PRACTICE-BASED LEARNING & QUALITY IMPROVEMENT INFORMATICS (Hoge et al., 2014)

Integrated Care Values

Person-centered Recovery-based Wellness-focused Family inclusive Culturally inclusive (CALMEND, 2011)

Implications

  • Stigma, embarrassment, interference with care seeking

Patient Problem

  • Role of PMHNP in integrated care setting
  • Progress towards PMHNP objectives:
  • access to behavioral health care; pt-centered care;

continuity of care; enhanced care of comorbid disorders; normalization of behavioral health issues; decrease in stigma

  • Patient: trust; movement towards recovery
  • Primary care clinic: better overall provision of

healthcare Application of integrated care values & care competencies

slide-8
SLIDE 8

APNA 29th Annual Conference Session 2022: October 29, 2015 Stover 8

Mental health is essential to overall health

Primary care settings Gateway for behavioral health and medical needs Improved mental/ behavioral health

Health/ wellness

Thank you for listening!

Reference Page

  • American Psychiatric Nurses Association. Introduction to integrated

physical and mental health care. Retrieved from http://www.apna.org/i4a/pages/index.cfm?pageID=4837

  • CalMEND. (2011). Integration of mental health, substance use, and primary

care services: Embracing our values from a client and family member perspective, vol. 1. Retrieved from www.integration.samhsa.gov/sliders/slider_10.3.pdf

  • Hoge M.A., Morris J.A., Laraia M., Pomerantz A., & Farley, T. (2014). Core

Competencies for Integrated Behavioral Health and Primary Care. Washington, DC: SAMHSA - HRSA Center for Integrated Health Solutions.

  • Lardieri, M. R., Lasky, G. B., & Raney, L. (2014, March). Essential

elements of effective integrated primary care and behavioral health teams. Washington, DC: SAMHSA – HRSA Center for Integrated Health

  • Solutions. Retrieved from www.integration.samhsa.gov
  • Levin, E. C. & Geiler, U. (2013). Delusions of parasitosis. Seminars in

Cutaneous Medicine and Surgery, 32, 73-77. doi: 10.12788/j.sder.0004

  • Pearson, M. L., Selby, J. V., Katz, K. A., Cantrell, V., Braden, C. R., Parise,
  • M. E., . . . Eberhard, M. L. (2012). Clinical, epidemiologic, histopathologic

and molecular features of an unexplained dermopathy. PLo5 One, 7(1),

  • e29908. doi: 10.1371/journal.pone.0029908
  • Prerost, F. J., Sefcik, D., & Smith, B. D. (2014). Differential diagnosis of

patients presenting with hallucinations. Osteopathic Family Physician, 2014(2), 19-24.

References